Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study.


Journal

Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637

Informations de publication

Date de publication:
11 01 2019
Historique:
received: 20 10 2018
accepted: 03 01 2019
entrez: 13 1 2019
pubmed: 13 1 2019
medline: 24 4 2019
Statut: epublish

Résumé

Diabetes mellitus (DM) is a prevalent metabolic disease characterized by chronic hyperglycemia. A primary burden of DM is related to its long-term complications, which have been shown to impact the course of hospitalization and to influence patients' outcome. To assess the role of in-hospital glucose control on length of stay, 30-days and 1-year mortality. This is a retrospective study that included patients admitted to the cardiac intensive care unit (CICU) of the Edith Wolfson Medical Centre between 01 January, 2010 and 31 December 2013. Blood glucose was measured by glucometer and fed into an interactive database. Glucose status was referred to as controlled when more than 50% of a given patients glucose values were between 71 and 200 mg/dL. Chisquared tests were used to assess the distribution of categorical variables, while the ttest was applied for continuous variables. A multivariate logistic regression model was used to analyze the association between glucose control and mortality. Cox regression was conducted to assess survival and 1-year mortality. 2466 patients were admitted to the CICU over the study period, of which 370 had concomitant diabetes mellitus. Controlled glucose status was associated with shorter length of hospital stay (1.6 ± 1.7 versus 2.6 ± 3.0, p < 0.001), reduced 30-day mortality (0.7% versus 4.6%, p < 0.001), and improved 1-year mortality (2.2% versus 7.5%, p < 0.001). Moreover, attainment of glucose control was independently associated with a significant decrease in 1-year mortality (OR = 0.371, 95% CI 0.140-0.988, p = 0.047). In-hospital control of glucose parameters is associated with shorter length of hospital stay, and lowered 30-day and 1-year mortality. An effort to maintain glucose levels within reference ranges is warranted in critically ill patients to reduce mortality.

Sections du résumé

BACKGROUND
Diabetes mellitus (DM) is a prevalent metabolic disease characterized by chronic hyperglycemia. A primary burden of DM is related to its long-term complications, which have been shown to impact the course of hospitalization and to influence patients' outcome.
AIM
To assess the role of in-hospital glucose control on length of stay, 30-days and 1-year mortality.
METHODS
This is a retrospective study that included patients admitted to the cardiac intensive care unit (CICU) of the Edith Wolfson Medical Centre between 01 January, 2010 and 31 December 2013. Blood glucose was measured by glucometer and fed into an interactive database. Glucose status was referred to as controlled when more than 50% of a given patients glucose values were between 71 and 200 mg/dL. Chisquared tests were used to assess the distribution of categorical variables, while the ttest was applied for continuous variables. A multivariate logistic regression model was used to analyze the association between glucose control and mortality. Cox regression was conducted to assess survival and 1-year mortality.
RESULTS
2466 patients were admitted to the CICU over the study period, of which 370 had concomitant diabetes mellitus. Controlled glucose status was associated with shorter length of hospital stay (1.6 ± 1.7 versus 2.6 ± 3.0, p < 0.001), reduced 30-day mortality (0.7% versus 4.6%, p < 0.001), and improved 1-year mortality (2.2% versus 7.5%, p < 0.001). Moreover, attainment of glucose control was independently associated with a significant decrease in 1-year mortality (OR = 0.371, 95% CI 0.140-0.988, p = 0.047).
CONCLUSION
In-hospital control of glucose parameters is associated with shorter length of hospital stay, and lowered 30-day and 1-year mortality. An effort to maintain glucose levels within reference ranges is warranted in critically ill patients to reduce mortality.

Identifiants

pubmed: 30634972
doi: 10.1186/s12933-019-0810-8
pii: 10.1186/s12933-019-0810-8
pmc: PMC6329158
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Références

Diabetes Care. 2015 Sep;38(9):1665-72
pubmed: 26180108
Circulation. 2002 Oct 15;106(16):2067-72
pubmed: 12379575
World J Diabetes. 2015 Aug 10;6(9):1082-91
pubmed: 26265994
Crit Care Med. 2007 Oct;35(10):2262-7
pubmed: 17717490
Diabetes Care. 2016 Aug;39 Suppl 2:S205-9
pubmed: 27440834
N Engl J Med. 2001 Nov 8;345(19):1359-67
pubmed: 11794168
J Clin Endocrinol Metab. 2015 Dec;100(12):4490-7
pubmed: 26485219
Minerva Cardioangiol. 2009 Apr;57(2):159-64
pubmed: 19274026
J Diabetes Res. 2016;2016:6989453
pubmed: 27822482
Chin Med J (Engl). 2018 Sep 5;131(17):2032-2040
pubmed: 30127212
Diabetes Care. 1995 Jun;18(6):870-8
pubmed: 7555517
BMJ. 1997 May 3;314(7090):1303-6
pubmed: 9158464
J Am Soc Nephrol. 2006 Jul;17(7):2034-47
pubmed: 16738019
Cardiovasc Diabetol. 2017 Aug 14;16(1):102
pubmed: 28806975
Dev Ophthalmol. 2017;60:1-5
pubmed: 28427059
Cardiovasc Diabetol. 2018 Aug 18;17(1):116
pubmed: 30121076
Stroke. 1999 Jan;30(1):34-9
pubmed: 9880385
Cardiovasc Diabetol. 2017 Dec 12;16(1):157
pubmed: 29233143
J Diabetes Sci Technol. 2009 Sep 01;3(5):1168-74
pubmed: 20144433
JAMA. 2006 Apr 12;295(14):1681-7
pubmed: 16609090
Am J Med. 2011 Nov;124(11):993-6
pubmed: 22017775
Chin Med J (Engl). 2017 Apr 5;130(7):767-775
pubmed: 28345539
N Engl J Med. 2009 Mar 26;360(13):1283-97
pubmed: 19318384
Congest Heart Fail. 2008 May-Jun;14(3):117-20
pubmed: 18550921
Crit Care. 2011 Jul 25;15(4):R173
pubmed: 21787410
Diabetes Metab J. 2015 Aug;39(4):273-82
pubmed: 26301188
BMC Nephrol. 2016 Aug 02;17(1):109
pubmed: 27484681
Int J Cardiol. 2016 Jan 15;203:587-93
pubmed: 26574932
Intern Med. 2013;52(21):2431-8
pubmed: 24190147

Auteurs

Kassem Sharif (K)

Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Suheil Ghadir (S)

Diabetes Unit, Wolfson Medical Center, Holon, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Daniela Jakubowicz (D)

Diabetes Unit, Wolfson Medical Center, Holon, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Howard Amital (H)

Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nicola Luigi Bragazzi (NL)

Postgraduate School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.

Abdulla Watad (A)

Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Julio Wainstein (J)

Diabetes Unit, Wolfson Medical Center, Holon, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yosefa Bar-Dayan (Y)

Diabetes Unit, Wolfson Medical Center, Holon, Israel. bardayan@netvision.net.il.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. bardayan@netvision.net.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH